C12Y 603/0201
Udp-n-acetylmuramoyl-tripeptide-d-alanyl-d-alanine ligase
Official title: UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-alanine ligase (6.3.2.10)
C12Y603/0201 (Udp-n-acetylmuramoyl-tripeptide-d-alanyl-d-alanine ligase) appears on 0 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 3
- Assignees
- 2
- Inventors
- 9
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Systems and method for screening small molecules of interest18 Nov 2021US 2021/0356467 A1Technology Innovation Momentum Fund (Israel) Limited Partnership
- Treatment of mycobacterium tuberculosis with antisense oligonucleotides17 Aug 2006US 2006/0183676 A1
- Novel purified polypeptides from streptococcus pneumoniae29 Sep 2005US 2005/0214918 A1Affinium Pharmaceuticals, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.